SWAN Capital »

Halozyme Therapeutics shares owned by SWAN Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by SWAN Capital from 13F filings

Historical chart of SWAN Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by SWAN Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by SWAN Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 18 57.22

More positions owned by SWAN Capital

Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Ishares Tr Pfd And Incm Sec (PFF)
Vanguard World Utilities Etf (VPU)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard World Energy Etf (VDE)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard World Inf Tech Etf (VGT)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Vanguard Index Fds Sml Cp Grw Etf (VBK)

View all positions for SWAN Capital

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics